Brief: Avenue Therapeutics Inc - On March 7, Board Voted To Expand Size Of Board From Five To Six Members
08/03/2023 22:06
March 8 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS INC - ON MARCH 7, BOARD VOTED TO
EXPAND
SIZE OF BOARD FROM FIVE TO SIX MEMBERS
* AVENUE THERAPEUTICS INC - ON MARCH 7, APPOINTED ALEXANDRA
MACLEAN, CEO OF CO, TO BOARD AS A DIRECTOR, EFFECTIVE
IMMEDIATELY
* AVENUE THERAPEUTICS INC - ON MARCH 7, BOARD APPOINTED JAY
KRANZLER TO SERVE AS CHAIRMAN OF BOARD, EFFECTIVE IMMEDIATELY
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary